298 related articles for article (PubMed ID: 19808192)
1. Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer.
Lennes IT; Lynch TJ
Clin Lung Cancer; 2009 Sep; 10(5):341-6. PubMed ID: 19808192
[TBL] [Abstract][Full Text] [Related]
2. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.
Hermens RP; Ouwens MM; Vonk-Okhuijsen SY; van der Wel Y; Tjan-Heijnen VC; van den Broek LD; Ho VK; Janssen-Heijnen ML; Groen HJ; Grol RP; Wollersheim HC
Lung Cancer; 2006 Oct; 54(1):117-24. PubMed ID: 16920220
[TBL] [Abstract][Full Text] [Related]
3. Quality of integrated care for patients with nonsmall cell lung cancer: variations and determinants of care.
Ouwens MM; Hermens RR; Termeer RA; Vonk-Okhuijsen SY; Tjan-Heijnen VC; Verhagen AF; Hulscher MM; Marres HA; Wollersheim HC; Grol RP
Cancer; 2007 Oct; 110(8):1782-90. PubMed ID: 17724680
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic standards and perspectives for stage IV non-small cell lung cancer].
Reck M; Rosell R; Tiemann M
Onkologie; 2012; 35 Suppl 3():10-3. PubMed ID: 22678019
[No Abstract] [Full Text] [Related]
5. Quality assessment in oncology.
Albert JM; Das P
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):773-81. PubMed ID: 22445001
[TBL] [Abstract][Full Text] [Related]
6. Practice guidelines for non-small cell lung cancer.
Cameron R; Fringer J; Taylor C; Gilden CR; Figlin RA
Cancer J Sci Am; 1996; 2(3A Suppl):S61-8. PubMed ID: 9166525
[No Abstract] [Full Text] [Related]
7. Consensus conference: multimodality management of early- and intermediate-stage non-small cell lung cancer.
Bordoni R
Oncologist; 2008 Sep; 13(9):945-53. PubMed ID: 18779538
[TBL] [Abstract][Full Text] [Related]
8. [Quality assurance].
Flentje M; Hoffmann H; Huber RM
Onkologie; 2012; 35 Suppl 3():14-6. PubMed ID: 22678020
[No Abstract] [Full Text] [Related]
9. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
Grossi F; Tiseo M
Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
[TBL] [Abstract][Full Text] [Related]
10. The effect of a lung cancer care coordination program on timeliness of care.
Alsamarai S; Yao X; Cain HC; Chang BW; Chao HH; Connery DM; Deng Y; Garla VN; Hunnibell LS; Kim AW; Obando JA; Taylor C; Tellides G; Rose MG
Clin Lung Cancer; 2013 Sep; 14(5):527-34. PubMed ID: 23827516
[TBL] [Abstract][Full Text] [Related]
11. Using nurse navigation to improve timeliness of lung cancer care at a veterans hospital.
Hunnibell LS; Rose MG; Connery DM; Grens CE; Hampel JM; Rosa M; Vogel DC
Clin J Oncol Nurs; 2012 Feb; 16(1):29-36. PubMed ID: 22297004
[TBL] [Abstract][Full Text] [Related]
12. Staging of non-small cell lung cancer (NSCLC): a review.
Tsim S; O'Dowd CA; Milroy R; Davidson S
Respir Med; 2010 Dec; 104(12):1767-74. PubMed ID: 20833010
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in the diagnosis and treatment of lung cancer.
Gilligan D
Int J Clin Pract; 1998; 52(5):330-4. PubMed ID: 9796565
[TBL] [Abstract][Full Text] [Related]
14. [Surgery and adjuvant therapy in non-small-cell lung carcinoma (NSCLC). (stage I through operable stage IIIA)].
Eberhardt W; Fietkau R; Griesinger F; Passlick B; Stuschke M
Onkologie; 2006 Sep; 29 Suppl 2():7-10. PubMed ID: 16974121
[No Abstract] [Full Text] [Related]
15. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
[TBL] [Abstract][Full Text] [Related]
16. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer.
Freeman RK; Van Woerkom JM; Vyverberg A; Ascioti AJ
Eur J Cardiothorac Surg; 2010 Jul; 38(1):1-5. PubMed ID: 20206544
[TBL] [Abstract][Full Text] [Related]
17. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Goss G; Paszat L; Newman TE; Evans WK; Browman G
Cancer Prev Control; 1998 Feb; 2(1):32-9. PubMed ID: 9765764
[TBL] [Abstract][Full Text] [Related]
18. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
[TBL] [Abstract][Full Text] [Related]
19. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
Wouters MW; Siesling S; Jansen-Landheer ML; Elferink MA; Belderbos J; Coebergh JW; Schramel FM
Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
[TBL] [Abstract][Full Text] [Related]
20. Adopting integrated care pathways in non-small-cell lung cancer: from theory to practice.
Fasola G; Rizzato S; Merlo V; Aita M; Ceschia T; Giacomuzzi F; Lugatti E; Meduri S; Morelli A; Rocco M; Tozzi V
J Thorac Oncol; 2012 Aug; 7(8):1283-90. PubMed ID: 22653077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
